Harbour BioMed inks $350 million deal for rights to A167
Member News

Related or similar articles
.png)
October 13, 2026
Biotech's Cathedral Problem: Rethinking Lab Space After the Boom
Discover the true cost of biotech lab space beyond rent and how shared labs help growing companies reduce overhead and scale more efficiently.
Blog Posts

May 6, 2025
How AI is Revolutionizing Biotech—and Why Labshares Remains the Ideal Home for Emerging Biotechs
AI is transforming biotech by accelerating drug discovery, diagnostics, and research. Emerging AI-biotech companies still need flexible wet lab space, advanced equipment, and experimental validation to bring discoveries to market.
Blog Posts
